You need a minimum of 2 studies to conduct a meta-analysis, as this is the smallest number that allows statistical pooling of effect estimates. However, 2 studies is a theoretical minimum, not a practical recommendation. Most methodologists and the Cochrane Handbook recommend having at least 5 studies for basic meta-analysis and 10 or more studies for reliable assessment of heterogeneity, publication bias, and subgroup differences.
The question of how many studies you need depends on what you want to do with the results. A simple pooled effect estimate can be calculated from 2 studies. But if you want to assess whether the effect varies across populations (subgroup analysis), investigate sources of variation (meta-regression and heterogeneity), test for funnel plot bias detection methods, or have confidence in the stability of your estimate (sensitivity analysis), you need substantially more studies.
The Theoretical Minimum: 2 Studies
A meta-analysis pools effect sizes from individual studies to produce a combined estimate with a narrower confidence interval than any single study. Mathematically, this pooling requires at least 2 data points. With 2 studies, you can calculate a weighted average effect size, a 95% confidence interval, and a basic Q-statistic for heterogeneity.
However, a 2-study meta-analysis has severe limitations:
- Heterogeneity is essentially unassessable. The Q-test has extremely low statistical power with 2 studies, and I-squared is unreliable with fewer than 5 studies
- The pooled estimate is fragile. If one study has a methodological flaw, it directly drives 50% of the result. There is no stability from additional studies to buffer against individual study weaknesses
- No publication bias assessment. learn about funnel plots and statistical tests for asymmetry cannot be used with 2 studies
- No subgroup analysis possible. You cannot investigate whether the effect varies by population, setting, or intervention characteristics
Despite these limitations, a 2-study meta-analysis is preferable to no synthesis when only 2 relevant studies exist. The Cochrane Handbook states that meta-analysis of 2 studies "may be valuable if both are large, rigorous, and clinically similar." Present individual study results alongside the pooled estimate and clearly communicate the limitations.
Practical Minimums by Analysis Type
| Analysis | Minimum Studies | Recommended | Rationale |
|---|---|---|---|
| Basic pooled estimate | 2 | 5+ | Stability of the combined effect |
| I-squared heterogeneity | 3 | 10+ | I-squared has low precision with few studies |
| Q-test for heterogeneity | 3 | 10+ | Very low statistical power below 10 studies |
| Subgroup analysis | 2 per subgroup | 5-10 per subgroup | Test for subgroup differences needs power |
| Meta-regression | 10 | 20+ | Rule of thumb: 10 studies per covariate |
| Funnel plot (visual) | 5 | 10+ | Patterns uninterpretable below 10 |
| Egger's test (statistical) | 10 | 20+ | Very low power below 10 studies |
| Trim-and-fill | 10 | 15+ | Requires sufficient studies for imputation |
| Sensitivity analysis | 3 | 5+ | Leave-one-out needs enough studies to be informative |
Why 10 Studies Is the Common Benchmark
The number 10 appears frequently in meta-analysis methodology guidelines as a minimum threshold for several reasons:
Heterogeneity assessment. The I-squared statistic measures the percentage of variability across studies that is due to true differences rather than chance. With fewer than 10 studies, the confidence interval around I-squared is so wide that the estimate is essentially uninformative. A meta-analysis of 4 studies might report I-squared of 50%, but the 95% confidence interval could range from 0% to 90%, making the value meaningless for decision-making. See our heterogeneity guide for interpretation details.
Publication bias detection. explore funnel plots require at least 10 studies to show visually interpretable patterns of asymmetry. Egger's regression test has very low statistical power below 10 studies, meaning it frequently fails to detect real publication bias when it exists. The Cochrane Handbook recommends against using these methods with fewer than 10 studies.
Model selection. Choosing between random effects and fixed effects models becomes more consequential with fewer studies. Random effects models, which are usually preferred because they account for between-study variation, produce wider confidence intervals that may encompass clinical irrelevance when the number of studies is small. With very few studies, the between-study variance estimate (tau-squared) is imprecise, affecting the validity of the random effects model.